Assetmark »

Xenon Pharmaceuticals shares owned by Assetmark

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Assetmark

Quarter filed Position value Share count Share price at filing
2023-12-31 $458k 9.9k 46.06
2023-09-30 $243k 7.1k 34.16
2023-06-30 $225k 5.8k 38.50

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Proshares Tr Pshs Ult S&p 500 (SSO)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Microsoft Corporation (MSFT)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Us Treas Bd Etf (GOVT)

View all positions for Assetmark

Top funds holding Xenon Pharmaceuticals

venBio Select Advisor
Wellington Management Company
Commodore Capital
Paradigm Biocapital Advisors
Braidwell
First Light Asset Management
Alliancebernstein
Marshall Wace
Citadel Advisors
Perceptive Advisors
Baker Bros. Advisors
Henderson Group
BVF
Point72 Asset Management
Avidity Partners Management

View all funds holding Xenon Pharmaceuticals